Sources

9 Total Sources

AstraZeneca Holds $400 Billion Merger Talks With Bristol Myers as Antitrust Risks Loom

Left43%
Center29%
Right29%
Financial Times20d ago
AstraZeneca, Bristol Myers Squibb Discuss Potential $400bn Pharma Merger
AskTraders21d ago
AstraZeneca and Bristol Myers Squibb in Merger Talks, FT Reports
TU News20d ago
AstraZeneca explores Bristol Myers Squibb merger to create nearly $400bn drug group
Fortune21d ago
AstraZeneca Explored Bristol Myers Squibb Acquisition for Megadeal
CNBC20d ago
AstraZeneca, Bristol Myers Squibb in $400 Billion Merger Talks
CNBC21d ago
AstraZeneca Considers $400 Billion Merger with Bristol Myers Squibb
Quartz20d ago
AstraZeneca, Bristol Myers Squibb Explore Potential $400 Billion Merger Talks
Yahoo Finance20d ago
AstraZeneca, Bristol-Myers Squibb Discuss Potential $400 Billion Merger
Seeking Alpha21d ago
AstraZeneca, Bristol Myers held merger talks, Financial Times reports (AZN:NYSE) | Seeking Alpha